Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Lundgrens El and Lås & Nycklar
Mandate

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Lundgrens El and Lås & Nycklar

March 18, 2021 M&A Employment and Benefits Corporate Tax Real Estate and Construction

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Lundgrens El-installationer Vikbolandet-Norrköping Aktiebolag and Lås & Nycklar i Norrköping AB.

The companies sell, design, install and perform services of all types of electricity, energy, telecommunications, data and security facilities and are based in Norrköping and Linköping. Together, the companies have around 90 employees with a turnover of approximately MSEK 200.

The acquisition is the Currentum Group’s first acquisition within the business area of electricity.

Vinge’s team consisted of partner Christina Kokko together with Karl Klackenberg, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Construction), Elin Broman (Employment) and Frida Ställborn (Real Estate).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025